Your browser doesn't support javascript.
loading
Palmitoylated antigens for the induction of anti-tumor CD8+ T cells and enhanced tumor recognition.
Stolk, Dorian A; Horrevorts, Sophie K; Schetters, Sjoerd T T; Kruijssen, Laura J W; Duinkerken, Sanne; Keuning, Eelco; Ambrosini, Martino; Kalay, Hakan; van de Ven, Rieneke; Garcia-Vallejo, Juan J; de Gruijl, Tanja D; van Vliet, Sandra J; van Kooyk, Yvette.
Afiliação
  • Stolk DA; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands.
  • Horrevorts SK; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands.
  • Schetters STT; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands.
  • Kruijssen LJW; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands.
  • Duinkerken S; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands.
  • Keuning E; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands.
  • Ambrosini M; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands.
  • Kalay H; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands.
  • van de Ven R; Amsterdam UMC, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands.
  • Garcia-Vallejo JJ; Amsterdam UMC, Department of Otolaryngology/Head and Neck Surgery, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands.
  • de Gruijl TD; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands.
  • van Vliet SJ; Amsterdam UMC, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands.
  • van Kooyk Y; Amsterdam UMC, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, Amsterdam Institute for Infection & Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands.
Mol Ther Oncolytics ; 21: 315-328, 2021 Jun 25.
Article em En | MEDLINE | ID: mdl-34141869
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda